loader image
Sunday, February 23, 2025
43.5 F
McAllen
We Welcome your Press Release
- Advertisement -

FREE  DIABETES  WALK,  SCREENINGS TO  BE  HELD  IN  VALLEY, Saturday November 8

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

SATURDAY,  NOV.  8

HARLINGEN – A free “Walk in the Park” Diabetes Walk will be held on Saturday, Nov. 8 at 8 a.m. at McKelvey Park, 1325 S. 77 Sunshine Strip, in Harlingen.  Free blood sugar testing, along with registration, will begin at 7 a.m. that morning. 

Speaker at the event will be Dr. Alfredo Garcia, Endocrinologist.  Participants can choose to walk one, two, or three miles.   T-shirts will be given to the first 400 registered walkers (including children).  Walkers will also receive a free hemoglobin A1c test for diabetes from the Valley Baptist Community Reference Lab.  In addition, there will be free foot screenings by Valley Baptist Wound care; healthy snacks; and face painting.  

- Advertisement -

In addition, participants at the event can ask questions to a doctor with the Valley Baptist Family Practice Residency Program, ask a pharmacist about medications, and / or talk with a dietitian from Aramark Healthcare about healthy eating.  For more information and to register, please call 1-888-902-5433.  Registration will also be available on site the morning of the event.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

UPDATE: Measles Outbreak

Mega Doctor News Mega Doctor News  As of February 18, 2025, the Texas...

DHR Health Celebrates 100th Ion Robotic-Assisted Bronchoscopy

DHR Health, a leader in healthcare serving the Rio Grande Valley, announced today that Dr. Federico Vallejo, pulmonologist, has successfully performed his 100th Ion robotic-assisted bronchoscopy.

DHR Health: Pioneering Alzheimer’s Treatment Breakthrough South of San Antonio

DHR Health, a leader in healthcare innovation, proudly announced today its groundbreaking achievement as the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved medication for the early treatment of Alzheimer’s disease. This milestone demonstrates their expertise and is a significant advancement in healthcare for the Rio Grande Valley.

FDA Approves First CRISPR Gene Therapy to Treat Sickle Cell Disease

Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.
- Advertisement -
×